53 related articles for article (PubMed ID: 17307470)
21. Na+/H+ exchanger inhibition at the onset of reperfusion decreases myocardial infarct size: role of reactive oxygen species.
Fantinelli JC; Cingolani HE; Mosca SM
Cardiovasc Pathol; 2006; 15(4):179-84. PubMed ID: 16844548
[TBL] [Abstract][Full Text] [Related]
22. Modulation of mitochondrial adenosine triphosphate-sensitive potassium channels and sodium-hydrogen exchange provide additive protection from severe ischemia-reperfusion injury.
Digerness SB; Brookes PS; Goldberg SP; Katholi CR; Holman WL
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):863-71. PubMed ID: 12698150
[TBL] [Abstract][Full Text] [Related]
23. Experimental studies on myocardial protection with intermittent cross-clamp fibrillation: additive effect of the sodium-hydrogen exchanger inhibitor, cariporide.
Fujii M; Avkiran M; Chambers DJ
Ann Thorac Surg; 2004 Apr; 77(4):1398-407. PubMed ID: 15063274
[TBL] [Abstract][Full Text] [Related]
24. The preischemic combination of the sodium-hydrogen exchanger inhibitor cariporide and the adenosine agonist AMP579 acts additively to reduce porcine myocardial infarct size.
Kristo G; Yoshimura Y; Ferraris SP; Jahania SA; Mentzer RM; Lasley RD
J Am Coll Surg; 2004 Oct; 199(4):586-94. PubMed ID: 15454144
[TBL] [Abstract][Full Text] [Related]
25. Sodium-hydrogen exchange inhibition and beta-blockade additively decrease infarct size.
Wang P; Zaragoza C; Holman W
Ann Thorac Surg; 2007 Mar; 83(3):1121-7. PubMed ID: 17307470
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic potential of novel Na+-Ca2+ exchange inhibitors in attenuating ischemia-reperfusion injury.
Lee C; Dhalla NS; Hryshko LV
Can J Cardiol; 2005 May; 21(6):509-16. PubMed ID: 15917880
[TBL] [Abstract][Full Text] [Related]
27. Cariporide Aventis.
Chin B; Lip GY
Curr Opin Investig Drugs; 2000 Nov; 1(3):340-6. PubMed ID: 11249717
[TBL] [Abstract][Full Text] [Related]
28. Cardiac protection during acute myocardial infarction: where do we stand in 2004?
Kloner RA; Rezkalla SH
J Am Coll Cardiol; 2004 Jul; 44(2):276-86. PubMed ID: 15261919
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological therapy for myocardial reperfusion injury.
Moukarbel GV; Ayoub CM; Abchee AB
Curr Opin Pharmacol; 2004 Apr; 4(2):147-53. PubMed ID: 15063358
[TBL] [Abstract][Full Text] [Related]
30. Sodium-hydrogen exchange inhibition: novel strategy to prevent myocardial injury following ischemia and reperfusion.
Buerke M; Rupprecht HJ; vom Dahl J; Terres W; Seyfarth M; Schultheiss HP; Richardt G; Sheehan FH; Drexler H
Am J Cardiol; 1999 May; 83(10A):19G-22G. PubMed ID: 10482176
[TBL] [Abstract][Full Text] [Related]
31. [Necrotic lesions, ischemia and reperfusion: effects of beta blockers].
Lechat P
Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():85-90. PubMed ID: 7905729
[TBL] [Abstract][Full Text] [Related]
32. Na+ overload-induced mitochondrial damage in the ischemic heart.
Takeo S; Tanonaka K
Can J Physiol Pharmacol; 2004 Dec; 82(12):1033-43. PubMed ID: 15644944
[TBL] [Abstract][Full Text] [Related]
33. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process.
Moens AL; Claeys MJ; Timmermans JP; Vrints CJ
Int J Cardiol; 2005 Apr; 100(2):179-90. PubMed ID: 15823623
[TBL] [Abstract][Full Text] [Related]
34. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia.
Avkiran M
Am J Cardiol; 1999 May; 83(10A):10G-17G; discussion 17G-18G. PubMed ID: 10482175
[TBL] [Abstract][Full Text] [Related]
35. Myocardial protection at a crossroads: the need for translation into clinical therapy.
Bolli R; Becker L; Gross G; Mentzer R; Balshaw D; Lathrop DA;
Circ Res; 2004 Jul; 95(2):125-34. PubMed ID: 15271864
[TBL] [Abstract][Full Text] [Related]
36. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
Dirksen MT; Laarman GJ; Simoons ML; Duncker DJ
Cardiovasc Res; 2007 Jun; 74(3):343-55. PubMed ID: 17306241
[TBL] [Abstract][Full Text] [Related]
37. Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1).
Tracey WR; Allen MC; Frazier DE; Fossa AA; Johnson CG; Marala RB; Knight DR; Guzman-Perez A
Cardiovasc Drug Rev; 2003; 21(1):17-32. PubMed ID: 12595915
[TBL] [Abstract][Full Text] [Related]
38. The role of the myocardial sodium-hydrogen exchanger in mediating ischemic and reperfusion injury. From amiloride to cariporide.
Karmazyn M
Ann N Y Acad Sci; 1999 Jun; 874():326-34. PubMed ID: 10415544
[TBL] [Abstract][Full Text] [Related]
39. Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1.
Gazmuri RJ; Ayoub IM; Kolarova JD; Karmazyn M
Crit Care Med; 2002 Apr; 30(4 Suppl):S166-71. PubMed ID: 11940795
[TBL] [Abstract][Full Text] [Related]
40. [Na+/H+ exchange inhibitors].
Hashimoto K
Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1140-4. PubMed ID: 10771686
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
